Literature DB >> 25458568

Transcriptional regulation of GAD1 GABA synthesis gene in the prefrontal cortex of subjects with schizophrenia.

Amanda C Mitchell1, Yan Jiang1, Cyril Peter1, Schahram Akbarian2.   

Abstract

Expression of GAD1 GABA synthesis enzyme is highly regulated by neuronal activity and reaches mature levels in the prefrontal cortex not before adolescence. A significant portion of cases diagnosed with schizophrenia show deficits in GAD1 RNA and protein levels in multiple areas of adult cerebral cortex, possibly reflecting molecular or cellular defects in subtypes of GABAergic interneurons essential for network synchronization and cognition. Here, we review 20years of progress towards a better understanding of disease-related regulation of GAD1 gene expression. For example, deficits in cortical GAD1 RNA in some cases of schizophrenia are associated with changes in the epigenetic architecture of the promoter, affecting DNA methylation patterns and nucleosomal histone modifications. These localized chromatin defects at the 5' end of GAD1 are superimposed by disordered locus-specific chromosomal conformations, including weakening of long-range promoter-enhancer loopings and physical disconnection of GAD1 core promoter sequences from cis-regulatory elements positioned 50 kilobases further upstream. Studies on the 3-dimensional architecture of the GAD1 locus in neurons, including developmentally regulated higher order chromatin compromised by the disease process, together with exploration of locus-specific epigenetic interventions in animal models, could pave the way for future treatments of psychosis and schizophrenia.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epigenetics; GABA; GAD1; Prefrontal cortex; Transcription factors

Mesh:

Substances:

Year:  2014        PMID: 25458568      PMCID: PMC4417100          DOI: 10.1016/j.schres.2014.10.020

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  127 in total

1.  Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development.

Authors:  S Akbarian; A Viñuela; J J Kim; S G Potkin; W E Bunney; E G Jones
Journal:  Arch Gen Psychiatry       Date:  1993-03

2.  Prefrontal cortical dysfunction during visual perspective-taking in schizophrenia.

Authors:  Shaun M Eack; Jessica A Wojtalik; Christina E Newhill; Matcheri S Keshavan; Mary L Phillips
Journal:  Schizophr Res       Date:  2013-09-19       Impact factor: 4.939

3.  Gamma-aminobutyric acid in the brain in schizophrenia.

Authors:  A J Cross; T J Crow; F Owen
Journal:  Lancet       Date:  1979-03-10       Impact factor: 79.321

4.  Boosting the power of schizophrenia genetics by leveraging new statistical tools.

Authors:  Ole A Andreassen; Wesley K Thompson; Anders M Dale
Journal:  Schizophr Bull       Date:  2013-12-06       Impact factor: 9.306

5.  GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression.

Authors:  Jong H Yoon; Richard J Maddock; Ariel Rokem; Michael A Silver; Michael J Minzenberg; J Daniel Ragland; Cameron S Carter
Journal:  J Neurosci       Date:  2010-03-10       Impact factor: 6.167

6.  Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia.

Authors:  Takanori Hashimoto; H Holly Bazmi; Karoly Mirnics; Qiang Wu; Allan R Sampson; David A Lewis
Journal:  Am J Psychiatry       Date:  2008-02-15       Impact factor: 18.112

7.  Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia.

Authors:  David A Lewis; Raymond Y Cho; Cameron S Carter; Kevin Eklund; Sarah Forster; Mary Ann Kelly; Debra Montrose
Journal:  Am J Psychiatry       Date:  2008-10-15       Impact factor: 18.112

8.  Involvement of the mirror neuron system in blunted affect in schizophrenia.

Authors:  Jung Suk Lee; Ji Won Chun; Sang Young Yoon; Hae-Jeong Park; Jae-Jin Kim
Journal:  Schizophr Res       Date:  2013-11-20       Impact factor: 4.939

Review 9.  Determining spatial chromatin organization of large genomic regions using 5C technology.

Authors:  Nynke L van Berkum; Job Dekker
Journal:  Methods Mol Biol       Date:  2009

10.  Rethinking schizophrenia in the context of normal neurodevelopment.

Authors:  Vibeke S Catts; Samantha J Fung; Leonora E Long; Dipesh Joshi; Ans Vercammen; Katherine M Allen; Stu G Fillman; Debora A Rothmond; Duncan Sinclair; Yash Tiwari; Shan-Yuan Tsai; Thomas W Weickert; Cynthia Shannon Weickert
Journal:  Front Cell Neurosci       Date:  2013-05-15       Impact factor: 5.505

View more
  19 in total

1.  HDAC1 links early life stress to schizophrenia-like phenotypes.

Authors:  Sanaz Bahari-Javan; Hristo Varbanov; Rashi Halder; Eva Benito; Lalit Kaurani; Susanne Burkhardt; Heike Anderson-Schmidt; Ion Anghelescu; Monika Budde; Roman M Stilling; Joan Costa; Juan Medina; Detlef E Dietrich; Christian Figge; Here Folkerts; Katrin Gade; Urs Heilbronner; Manfred Koller; Carsten Konrad; Sara Y Nussbeck; Harald Scherk; Carsten Spitzer; Sebastian Stierl; Judith Stöckel; Andreas Thiel; Martin von Hagen; Jörg Zimmermann; Antje Zitzelsberger; Sybille Schulz; Andrea Schmitt; Ivana Delalle; Peter Falkai; Thomas G Schulze; Alexander Dityatev; Farahnaz Sananbenesi; André Fischer
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-22       Impact factor: 11.205

2.  GABA and schizophrenia: Where we stand and where we need to go.

Authors:  Jill R Glausier; David A Lewis
Journal:  Schizophr Res       Date:  2017-02-05       Impact factor: 4.939

3.  Cocaine-Induced Chromatin Modifications Associate With Increased Expression and Three-Dimensional Looping of Auts2.

Authors:  Olivia Engmann; Benoit Labonté; Amanda Mitchell; Pavel Bashtrykov; Erin S Calipari; Chaggai Rosenbluh; Yong-Hwee E Loh; Deena M Walker; Dominika Burek; Peter J Hamilton; Orna Issler; Rachael L Neve; Gustavo Turecki; Yasmin Hurd; Andrew Chess; Li Shen; Isabelle Mansuy; Albert Jeltsch; Schahram Akbarian; Eric J Nestler
Journal:  Biol Psychiatry       Date:  2017-05-05       Impact factor: 13.382

4.  Maternal immune activation induces GAD1 and GAD2 promoter remodeling in the offspring prefrontal cortex.

Authors:  Marie Anaïs Labouesse; Erbo Dong; Dennis Robert Grayson; Alessandro Guidotti; Urs Meyer
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

Review 5.  Genetic insights into the neurodevelopmental origins of schizophrenia.

Authors:  Rebecca Birnbaum; Daniel R Weinberger
Journal:  Nat Rev Neurosci       Date:  2017-10-26       Impact factor: 34.870

Review 6.  Understanding the genetic liability to schizophrenia through the neuroepigenome.

Authors:  John F Fullard; Tobias B Halene; Claudia Giambartolomei; Vahram Haroutunian; Schahram Akbarian; Panos Roussos
Journal:  Schizophr Res       Date:  2016-01-27       Impact factor: 4.939

7.  Exercise Ameliorates Fluoride-induced Anxiety- and Depression-like Behavior in Mice: Role of GABA.

Authors:  Qiqi Cao; Jixiang Wang; Yanru Hao; Fangye Zhao; Rong Fu; Yanghuan Yu; Jundong Wang; Ruiyan Niu; Shengtai Bian; Zilong Sun
Journal:  Biol Trace Elem Res       Date:  2021-04-06       Impact factor: 3.738

8.  Bridging the Gap between Genes and Language Deficits in Schizophrenia: An Oscillopathic Approach.

Authors:  Elliot Murphy; Antonio Benítez-Burraco
Journal:  Front Hum Neurosci       Date:  2016-08-23       Impact factor: 3.169

9.  Interacting Roles of COMT and GAD1 Genes in Patients with Treatment-Resistant Schizophrenia: a Genetic Association Study of Schizophrenia Patients and Healthy Controls.

Authors:  Masanobu Kogure; Nobuhisa Kanahara; Atsuhiro Miyazawa; Kengo Oishi; Yusuke Nakata; Yasunori Oda; Masaomi Iyo
Journal:  J Mol Neurosci       Date:  2021-06-14       Impact factor: 3.444

10.  Weak Association Between the Glutamate Decarboxylase 1 Gene (GAD1) and Schizophrenia in Han Chinese Population.

Authors:  Luwen Zhang; Zhen Li; Qing Liu; Minglong Shao; Fuping Sun; Xi Su; Meng Song; Yan Zhang; Minli Ding; Yanli Lu; Jiewei Liu; Yongfeng Yang; Ming Li; Wenqiang Li; Luxian Lv
Journal:  Front Neurosci       Date:  2021-06-21       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.